ST Pharm Co Ltd

237690.KQ

$75.31

Closing

▲5.93%

1D

▲50.15%

YTD

Market cap

$1.43B

52 week high

$76.27

52 week low

$44.31

Volume

489,794

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$1.43B

Analysts' Rating

STRONG BUY

Price Target (Mean)

0.00

Total Analysts

2

P/E

87.09

Operating Margin

0.00%

Beta

0.97

Revenue Growth (Annual)

-

52 week high

$76.27

52 week low

$44.31

Div. Yield

0.49%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

STPharm Co.,Ltd. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The Company’s products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The Company distributes its products within domestic market and to overseas markets.